Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
Samsung Bioepis, a business of South Korea-based Samsung BioLogics has outlined data it is presenting at the ongoing congress of the European Academy of Dermato 11 October 2023
The market for biosimilar versions of AbbVie’s mega-blockbuster TNF blocker Humira (adalimumab) is hotting up, with a major price reduction from Boehringer Inge 4 October 2023
A Chinese contract development and manufacturing organization (CDMO), Chime Biologics, has announced a strategic cooperation with South Korea’s Kings Pharm. 29 September 2023
The date for the generics and biosimilars specialist Sandoz to spin out from its parent company Novartis (NOVN: VX) has been announced. 25 September 2023
Chicago, USA-based Meitheal Pharmaceuticals has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceutical to commercialize three insulin bi 22 September 2023